Antitumor Effect of (131)I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer

Anaplastic thyroid cancer (ATC) comprises approximately 2% of all thyroid cancers, and its median survival rate remains poor because of its resistance to conventional therapy. Vascular endothelial growth factor receptor (VEGFR)-targeted therapeutics-loaded mesoporous silica nanoparticles represent a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nanoscale Res Lett
Autors principals: Zhang, Ruiguo, Zhang, Yueqian, Tan, Jian, Wang, Hanjie, Zhang, Guizhi, Li, Ning, Meng, Zhaowei, Zhang, Fuhai, Chang, Jin, Wang, Renfei
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2019
Matèries:
Nano Express
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419646/
https://ncbi.nlm.nih.gov/pubmed/30874973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11671-019-2924-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars